Don't Jump to Combo Med Duzallo for Chronic Gout
November 2017
Duzallo (doo-ZAL-oh) will be a new chronic gout med that combines lesinurad with allopurinol.
Reps will tout Duzallo as a combo that targets both causes of gout. Allopurinol decreases uric acid production...and lesinurad (Zurampic) increases renal uric acid excretion, similar to probenecid.
Duzallo helps about one more in 4 patients reach uric acid goals...compared to about 300 mg/day of allopurinol alone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote